1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. North America Biologics Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Chronic Diseases

4.1.2 Preference for Outsourcing Manufacturing Operations

4.2 Market Restraints

4.2.1 High Cost of Biologics

4.3 Market Opportunities

4.3.1 Gene and Cell Therapy Advancements in Biologics

4.4 Future Trends

4.4.1 Strategic Initiatives by Companies

4.5 Impact of Drivers and Restraints:

5. Biologics Market - North America Analysis

5.1 North America Biologics Market Revenue (US$ Million), 2021-2031

5.2 North America Biologics Market Forecast Analysis

6. North America Biologics Market Analysis - by Product

6.1 Monoclonal Antibodies

6.1.1 Overview

6.1.2 Monoclonal Antibodies: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.2 Vaccine

6.2.1 Overview

6.2.2 Vaccine: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.3 Recombinant Hormones/Proteins

6.3.1 Overview

6.3.2 Recombinant Hormones/Proteins: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.4 Cell and Gene Therapy

6.4.1 Overview

6.4.2 Cell and Gene Therapy: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.5 Others

6.5.1 Overview

6.5.2 Others: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Biologics Market Analysis - by Application

7.1 Cancer

7.1.1 Overview

7.1.2 Cancer: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Infectious Diseases

7.2.1 Overview

7.2.2 Infectious Diseases: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Autoimmune Diseases

7.3.1 Overview

7.3.2 Autoimmune Diseases: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Biologics Market Analysis - by Source

8.1 Mammalian

8.1.1 Overview

8.1.2 Mammalian: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Microbial

8.2.1 Overview

8.2.2 Microbial: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Biologics Market Analysis - by Manufacturing

9.1 Outsourced

9.1.1 Overview

9.1.2 Outsourced: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.2 In-house

9.2.1 Overview

9.2.2 In-house: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Biologics Market - Country Analysis

10.1 North America

10.1.1 North America Biologics Market - Revenue and Forecast Analysis - by Country

10.1.1.1 North America Biologics Market - Revenue and Forecast Analysis - by Country

10.1.1.2 United States: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.2.1 United States: North America Biologics Market Share - by Product

10.1.1.2.2 United States: North America Biologics Market Share - by Application

10.1.1.2.3 United States: North America Biologics Market Share - by Source

10.1.1.2.4 United States: North America Biologics Market Share - by Manufacturing

10.1.1.3 Canada: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.3.1 Canada: North America Biologics Market Share - by Product

10.1.1.3.2 Canada: North America Biologics Market Share - by Application

10.1.1.3.3 Canada: North America Biologics Market Share - by Source

10.1.1.3.4 Canada: North America Biologics Market Share - by Manufacturing

10.1.1.4 Mexico: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.4.1 Mexico: North America Biologics Market Share - by Product

10.1.1.4.2 Mexico: North America Biologics Market Share - by Application

10.1.1.4.3 Mexico: North America Biologics Market Share - by Source

10.1.1.4.4 Mexico: North America Biologics Market Share - by Manufacturing

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 AbbVie Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Pfizer Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Samsung Biologics Co Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 ADMA Biologics, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 WuXi Biologics Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Catalent Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 AGC Biologics AS

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 AstraZeneca Plc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Amgen Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Nitto Avecia

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 Quality Assistance s.a.

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

13. Appendix

13.1 About Us

List of Tables

Table 1. North America Biologics Market Segmentation

Table 2. North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Table 3. North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product

Table 4. North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application

Table 5. North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source

Table 6. North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Manufacturing

Table 7. North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country

Table 8. United States: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 9. United States: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 10. United States: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 11. United States: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 12. Canada: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 13. Canada: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 14. Canada: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 15. Canada: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 16. Mexico: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 17. Mexico: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 18. Mexico: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 19. Mexico: North America Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

List of Figures

Figure 1. North America Biologics Market Segmentation - Country

Figure 2. North America Biologics Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Biologics Market Revenue (US$ Million), 2021-2031

Figure 5. North America Biologics Market Share (%) - by Product (2023 and 2031)

Figure 6. Monoclonal Antibodies: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 7. Vaccine: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 8. Recombinant Hormones/Proteins: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 9. Cell and Gene Therapy: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 10. Others: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 11. North America Biologics Market Share (%) - by Application (2023 and 2031)

Figure 12. Cancer: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 13. Infectious Diseases: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 14. Autoimmune Diseases: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 15. Others: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 16. North America Biologics Market Share (%) - by Source (2023 and 2031)

Figure 17. Mammalian: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 18. Microbial: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 19. North America Biologics Market Share (%) - by Manufacturing (2023 and 2031)

Figure 20. Outsourced: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 21. In-house: North America Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 22. North America Biologics Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 23. United States: North America Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 24. Canada: North America Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 25. Mexico: North America Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)